智能生物学实验室(IBLab)

Institute of Medical Genetics and Genomics, Fudan University. Research Building 2, No. 131 Dong'an Road, Xuhui District, Shanghai, China. yuanbo@ion.ac.cn · 021-54231035.

prof_pic.jpg

Intelligent Biology Laboratory (IBLab)

Research Building 2, No. 131 Dong'an Road

Xuhui District, Shanghai, China 200032

yuanbo@ion.ac.cn · 021-54231035

Dr. Bo Yuan is a Junior Principal Investigator and Supervisor of Master’s Students at the Institute of Medical Genetics and Genomics, Fudan University. He received his B.S. in Biological Sciences from Zhejiang University in 2010 and his Ph.D. in Neurobiology from the University of Chinese Academy of Sciences in 2017 (advisor: Dr. Zilong Qiu). After graduation, he stayed at the Institute of Neuroscience, Chinese Academy of Sciences (now Center for Excellence in Brain Science and Intelligence Technology), serving as Assistant Investigator, Associate Investigator, and Director of the High-Performance Computing Cluster. In October 2024, he joined Fudan University and established the Intelligent Biology Laboratory.

Dr. Yuan focuses on the genetic mechanisms and precision interventions of neurodevelopmental disorders such as autism spectrum disorder. Along the research chain of “genetic discovery — tool innovation — in vivo validation,” he has accumulated continuous expertise in population genetics, molecular mechanisms, gene-editing tool development, and disease modeling. He has published papers as first or co-first author in Molecular Psychiatry, Nature Communications, Nucleic Acids Research, Neuroscience Bulletin, and other journals, and has led projects funded by the National Natural Science Foundation of China and the Shanghai Natural Science Foundation.

The Intelligent Biology Laboratory (IBLab) is affiliated with the Institute of Medical Genetics and Genomics, Fudan University. We focus on the genetic basis, pathogenic mechanisms, and precision intervention strategies of neurodevelopmental disorders such as autism spectrum disorder. By integrating population genetics, genomics, brain organoids and assembloids, gene editing, and artificial intelligence, we aim to build a continuous evidence chain from risk-gene identification to intervention-parameter optimization.

Our research directions include:

  1. Pathogenic mechanisms and intervention strategies of neuropsychiatric candidate genes in the Chinese population;
  2. Human developmental models based on iPSC-derived brain organoids and assembloids;
  3. AI- and structure-guided optimization of gene-editing tools, especially base editors;
  4. High-performance computing and multi-omics data integration methods.

The lab leverages the platforms of Fudan University’s Medical Research Data Center and CFFF High-Performance Computing Platform to enable interdisciplinary “wet-and-dry” research.

We are recruiting motivated students and collaborators. If you are interested in joining us, please contact Dr. Yuan at yuanbo@ion.ac.cn.

news

Dec 31, 2025 Commentary “Re-examining interneuron-specific Nrp2 deletion: overlooked striatal and cortical contributions” was published in Molecular Psychiatry.
Dec 31, 2024 Collaborative paper “Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins” was published in Nature Communications.
Dec 14, 2024 The laboratory joined the National Key R&D Program key special project on reproductive health and women and children’s health as a core participant.
Nov 30, 2024 The laboratory was awarded a Shanghai Natural Science Foundation General Program grant on mitochondrial dysfunction candidate genes in the Chinese autism cohort.
Sep 30, 2024 Dr. Bo Yuan joined the Institute of Medical Genetics and Genomics, Fudan University, and established the Intelligent Biology Laboratory (IBLab).

latest posts

Mar 26, 2025 a post with plotly.js
Dec 04, 2024 a post with image galleries
May 01, 2024 a post with tabs

selected publications

  1. Re-examining interneuron-specific Nrp2 deletion: overlooked striatal and cortical contributions
    AiHua Yuan, and Bo Yuan
    Molecular Psychiatry, 2025
    Accepted
  2. Effective in vivo RNA base editing via engineered cytidine deaminase APOBECs fused with PUF proteins
    WenJian Han, Bo Yuan, XiaoJuan Fan, and 8 more authors
    Nature Communications, 2025
    Accepted
  3. Whole-brain in vivo base editing reverses behavioral changes in Mef2c-mutant mice
    WeiKe Li, ShuQian Zhang, WanLing Peng, and 15 more authors
    Nature Neuroscience, 2025
  4. Identification of de novo mutations in the Chinese ASD cohort via whole-exome sequencing unveils brain regions implicated in autism
    Bo Yuan, MengDi Wang, XinRan Wu, and 8 more authors
    Neuroscience Bulletin, 2023
  5. Engineering of cytosine base editors with genotoxicity minimization and editing scope diversification
    Bo Yuan, ShuQian Zhang, LiTing Song, and 7 more authors
    Nucleic Acids Research, 2023
  6. TadA orthologs enable both cytosine and adenine editing of base editors
    ShuQian Zhang, Bo Yuan, JiXin Cao, and 7 more authors
    Nature Communications, 2023
  7. TadA reprogramming to generate potent miniature base editors with high precision
    ShuQian Zhang, LiTing Song, Bo Yuan, and 9 more authors
    Nature Communications, 2023
  8. Novel IL1RAP mutation associated with schizophrenia interferes with neuronal growth and related NF-κB signal pathways
    PeiPei Cheng, Ran Zhang, ShiFang Shan, and 4 more authors
    Neuroscience Letters, 2022
  9. Identification of CHMP4C as a new risk gene for inherited dilated cardiomyopathy
    NianWei Zhou, Lu Tang, YingYing Jiang, and 9 more authors
    Journal of Genetics and Genomics, 2022
  10. An intronic variant of CHD7 identified in autism patients interferes with neuronal differentiation and development
    Ran Zhang, Hui He, Bo Yuan, and 5 more authors
    Neuroscience Bulletin, 2021
  11. Visualization and correction of social abnormalities-associated neural ensembles in adult MECP2 duplication mice
    Le Sun, RuiGuo Chen, Long Li, and 11 more authors
    Science Bulletin, 2020
  12. Reversal of social recognition deficit in adult mice with MECP2 duplication via normalization of MeCP2 in the medial prefrontal cortex
    Bin Yu, Bo Yuan, Jian-Kun Dai, and 9 more authors
    Neuroscience Bulletin, 2020
  13. Docking sites inside Cas9 for adenine base editing diversification and RNA off-target elimination
    Shuo Li, Bo Yuan, JiXin Cao, and 7 more authors
    Nature Communications, 2020
  14. Expanding C-T base editing toolkit with diversified cytidine deaminases
    Tian-Lin Cheng, Shuo Li, Bo Yuan, and 3 more authors
    Nature Communications, 2019
  15. Towards the framework of understanding autism spectrum disorders
    ZiLong Qiu, and Bo Yuan
    Neuroscience Bulletin, 2019
  16. Mir505-3p regulates axonal development via inhibiting the autophagy pathway by targeting Atg12
    Kan Yang, Bin Yu, Cheng Cheng, and 6 more authors
    Autophagy, 2017
  17. Accumulated quiescent neural stem cells in adult hippocampus of the mouse model for the MECP2 duplication syndrome
    ZhiFang Che, Xiao Li, JingJing Zhou, and 12 more authors
    Scientific Reports, 2017
  18. Autism-related protein MeCP2 regulates FGF13 expression and emotional behaviors
    Bo Yuan, Tian-Lin Cheng, Kan Yang, and 2 more authors
    Journal of Genetics and Genomics, 2017
  19. Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs
    Jing-Wen Lyu, Bo Yuan, Tian-Lin Cheng, and 2 more authors
    Scientific Reports, 2016
  20. Tet1-mediated DNA demethylation regulates neuronal cell death induced by oxidative stress
    Yong-Juan Xin, Bo Yuan, Bin Yu, and 4 more authors
    Scientific Reports, 2015
  21. NeuroD2 regulates the development of hippocampal mossy fiber synapses
    Scott A Wilke, Benjamin J Hall, Joseph K Antonios, and 10 more authors
    Neural Development, 2012